HYPOTHALAMIC-PITUITARY-OVARIAN AXIS IN WOMEN WITH EPILEPSY

女性癫痫患者的下丘脑-垂体-卵巢轴

基本信息

  • 批准号:
    6115032
  • 负责人:
  • 金额:
    $ 4.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-12-01 至 1999-11-30
  • 项目状态:
    已结题

项目摘要

Women with epilepsy may be at risk for reproductive health dysfunctions, including menstrual irregularity, anovulation, polycystic ovarian syndrome, and disturbances in basal and pulsatile release of gonadotropins and ovarian steroids. This study will define reproductive health risks for women with epilepsy and determine the relative mechanistic contribution of epilepsy syndrome, seizure frequency and type, and of individual antiepileptic drugs (AEDs) used in monotherapy. Pituitary and gonodal hormones, ovulatory function and ovarian morphology, and luteal phase function/adequacy will be evaluated in women with one of three distinct epilepsy syndromes: (1) idiopathic primary generalized epilepsy (PGE), in which the cerebral cortex is structurally and functionally normal; (2) symptomatic, localization related epilepsy (LRE) of temporal lobe origin, in which there is a structural and /or function functional lesion within the temporal lobe; and (3) LRE of extratemporal lobe origin in which the epileptogenic region resides outside of the temporal lobe. These indices of reproductive functions will also be evaluated according to exposure to AEDs in monotherapy that either induce, inhibit, or do not alter the hepatic mixed-function cytochrome P 450 enzyme system. Women with LRE of temporal lobe origin are hypothesized to be preferentially at risk for reproductive health dysfunctions because, given the extensive input of lesion is likely to cause hypothalamic- pituitary axis sysfunction. In addition, AEDs which inhibit P450 will increase steroid hormone concentrations and may predispose to reproductive dysfunctions. The effects of temporal lobe epilepsy versus AEDs before and after surgical resection of a temporal lobe epileptogenic focus, after which seizures are likety to remit while AEDs are held constant. These findings will permit the clinician to select an AED which is least likely to compromise reproductive health for a given epilepsy syndrome, and will make it more likely that women with epilepsy and reproductive dysfunction are identified and appropriately treated.
Women with epilepsy may be at risk for reproductive health dysfunctions, including menstrual irregularity, anovulation, polycystic ovarian syndrome, and disturbances in basal and pulsatile release of gonadotropins and ovarian steroids. This study will define reproductive health risks for women with epilepsy and determine the relative mechanistic contribution of epilepsy syndrome, seizure frequency and type, and of individual antiepileptic drugs (AEDs) used in monotherapy. Pituitary and gonodal hormones, ovulatory function and ovarian morphology, and luteal phase function/adequacy will be evaluated in women with one of three distinct epilepsy syndromes: (1) idiopathic primary generalized epilepsy (PGE), in which the cerebral cortex is structurally and functionally normal; (2) symptomatic, localization related epilepsy (LRE) of temporal lobe origin, in which there is a structural and /or function functional lesion within the temporal lobe; and (3) LRE of extratemporal lobe origin in which the epileptogenic region resides outside of the temporal lobe. These indices of reproductive functions will also be evaluated according to exposure to AEDs in monotherapy that either induce, inhibit, or do not alter the hepatic mixed-function cytochrome P 450 enzyme system. Women with LRE of temporal lobe origin are hypothesized to be preferentially at risk for reproductive health dysfunctions because, given the extensive input of lesion is likely to cause hypothalamic- pituitary axis sysfunction. In addition, AEDs which inhibit P450 will increase steroid hormone concentrations and may predispose to reproductive dysfunctions. The effects of temporal lobe epilepsy versus AEDs before and after surgical resection of a temporal lobe epileptogenic focus, after which seizures are likety to remit while AEDs are held constant. These findings will permit the clinician to select an AED which is least likely to compromise reproductive health for a given epilepsy syndrome, and will make it more likely that women with epilepsy and reproductive dysfunction are identified and appropriately treated.

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARTHA J MORRELL其他文献

MARTHA J MORRELL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARTHA J MORRELL', 18)}}的其他基金

Thalamocortical Responsive Neurostimulation for the Treatment of Lennox-Gastaut Syndrome
丘脑皮质反应性神经刺激治疗 Lennox-Gastaut 综合征
  • 批准号:
    10615330
  • 财政年份:
    2021
  • 资助金额:
    $ 4.03万
  • 项目类别:
Thalamocortical Responsive Neurostimulation for the Treatment of Lennox-Gastaut Syndrome
丘脑皮质反应性神经刺激治疗 Lennox-Gastaut 综合征
  • 批准号:
    9958791
  • 财政年份:
    2021
  • 资助金额:
    $ 4.03万
  • 项目类别:
Thalamocortical Responsive Neurostimulation for the Treatment of Lennox-Gastaut Syndrome
丘脑皮质反应性神经刺激治疗 Lennox-Gastaut 综合征
  • 批准号:
    10674542
  • 财政年份:
    2021
  • 资助金额:
    $ 4.03万
  • 项目类别:
Thalamocortical Responsive Neurostimulation for the Treatment of Lennox-Gastaut Syndrome
丘脑皮质反应性神经刺激治疗 Lennox-Gastaut 综合征
  • 批准号:
    10414867
  • 财政年份:
    2021
  • 资助金额:
    $ 4.03万
  • 项目类别:
BONE HEALTH IN EPILEPSY
癫痫症的骨骼健康
  • 批准号:
    7205896
  • 财政年份:
    2005
  • 资助金额:
    $ 4.03万
  • 项目类别:
Bone Health in Epilepsy
癫痫症的骨骼健康
  • 批准号:
    7045009
  • 财政年份:
    2003
  • 资助金额:
    $ 4.03万
  • 项目类别:
Reproductive Function in Women with Bipolar Disorders
双相情感障碍女性的生殖功能
  • 批准号:
    7045027
  • 财政年份:
    2003
  • 资助金额:
    $ 4.03万
  • 项目类别:
EFFECTS OF ANTIEPILEPTIC DRUGS ON BONE TURNOVER AND MASS
抗癫痫药物对骨转换和质量的影响
  • 批准号:
    6567729
  • 财政年份:
    2001
  • 资助金额:
    $ 4.03万
  • 项目类别:
EFFECTS OF ANTIEPILEPTIC DRUGS ON BONE TURNOVER AND MASS
抗癫痫药物对骨转换和质量的影响
  • 批准号:
    6468469
  • 财政年份:
    2000
  • 资助金额:
    $ 4.03万
  • 项目类别:
ANALYSIS OF BONE HEALTH IN AED EXPOSED WOMEN WITH EPILEPSY
暴露于 AED 的癫痫女性的骨骼健康分析
  • 批准号:
    6115081
  • 财政年份:
    1998
  • 资助金额:
    $ 4.03万
  • 项目类别:

相似海外基金

Replacing valproate with a safer, broad-spectrum drug for epilepsy treatment
用更安全的广谱药物替代丙戊酸治疗癫痫
  • 批准号:
    MR/Y019334/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Research Grant
Longitudinal structural and cognitive functional imaging and outcome prediction in focal epilepsy treated with gene therapy and surgical resection.
基因治疗和手术切除治疗局灶性癫痫的纵向结构和认知功能成像及结果预测。
  • 批准号:
    MR/X031039/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Research Grant
Investigation of the pathogenesis and establishing the pharmacotherapy for the early repolarization syndrome and refractory epilepsy caused by KCND3 variants using iPSC models.
使用 iPSC 模型研究 KCND3 变异引起的早期复极综合征和难治性癫痫的发病机制并建立药物治疗。
  • 批准号:
    24K19074
  • 财政年份:
    2024
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Visualization of Early Seizure Propagation Dynamics Focusing on Flexibility in Epilepsy Networks
早期癫痫传播动力学的可视化,重点关注癫痫网络的灵活性
  • 批准号:
    23K15651
  • 财政年份:
    2023
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Engineering a novel mitochondrial-targeting drug for epilepsy in tuberous sclerosis complex
设计一种新型线粒体靶向药物治疗结节性硬化症癫痫
  • 批准号:
    2887960
  • 财政年份:
    2023
  • 资助金额:
    $ 4.03万
  • 项目类别:
    Studentship
Imaging Epilepsy Sources with Biophysically Constrained Deep Neural Networks
使用生物物理约束的深度神经网络对癫痫源进行成像
  • 批准号:
    10655833
  • 财政年份:
    2023
  • 资助金额:
    $ 4.03万
  • 项目类别:
Motion Compensated fMRI for Pre-Surgical Planning in Epilepsy
用于癫痫手术前规划的运动补偿功能磁共振成像
  • 批准号:
    10659634
  • 财政年份:
    2023
  • 资助金额:
    $ 4.03万
  • 项目类别:
Methylphenidate for the treatment of epilepsy-related cognitive deficits: a randomized, double-blind, placebo-controlled trial
哌醋甲酯治疗癫痫相关认知缺陷:一项随机、双盲、安慰剂对照试验
  • 批准号:
    10589709
  • 财政年份:
    2023
  • 资助金额:
    $ 4.03万
  • 项目类别:
Changes in the Ionic Basis of GABAergic Inhibition that Contribute to Post-traumatic Epilepsy
导致创伤后癫痫的 GABA 能抑制离子基础的变化
  • 批准号:
    10713240
  • 财政年份:
    2023
  • 资助金额:
    $ 4.03万
  • 项目类别:
EEG Biomarkers Derived from Dynamical Network Models Enable Rapid Paths to Accurate Diagnosis and Effective Treatment of Epilepsy
源自动态网络模型的脑电图生物标志物为癫痫的准确诊断和有效治疗提供了快速途径
  • 批准号:
    10665213
  • 财政年份:
    2023
  • 资助金额:
    $ 4.03万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了